BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 8901216)

  • 1. [Evaluation on a gastric mass survey-comparison with gastric mass screening using photofluorography and that using serum pepsinogen].
    Tomooka Y
    Nihon Koshu Eisei Zasshi; 1996 Feb; 43(2):118-25. PubMed ID: 8901216
    [No Abstract]   [Full Text] [Related]  

  • 2. The usefulness of gastric mass screening using serum pepsinogen levels compared with photofluorography.
    Yoshihara M; Sumii K; Haruma K; Kiyohira K; Hattori N; Tanaka S; Kajiyama G; Shigenobu T
    Hiroshima J Med Sci; 1997 Jun; 46(2):81-6. PubMed ID: 9232936
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Mass screening of stomach neoplasms by serum pepsinogen analysis].
    Miki K
    Nihon Naika Gakkai Zasshi; 1992 May; 81(5):654-9. PubMed ID: 1512496
    [No Abstract]   [Full Text] [Related]  

  • 4. A minute gastric cancer detected by a new screening method using serum pepsinogen I and II.
    Yahagi N; Miki K; Ichinose M; Kakei N; Matsushima M; Kido M; Shimizu Y; Ishihama S; Tsukada S; Kurokawa K
    Adv Exp Med Biol; 1995; 362():145-8. PubMed ID: 8540313
    [No Abstract]   [Full Text] [Related]  

  • 5. [Mass screening of gastric cancer--limits and prospects].
    Yamaki G; Higashi K
    Gan To Kagaku Ryoho; 2002 Nov; 29(11):1883-7. PubMed ID: 12465385
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Two cases of early colorectal cancer associated with gastric adenoma detected by serum pepsinogen screening method.
    Shimizu Y; Kakei N; Wada T; Yahagi N; Kido M; Ishihama S; Tsukada S; Matsushima M; Ichinose M; Miki K
    Adv Exp Med Biol; 1995; 362():149-54. PubMed ID: 8540314
    [No Abstract]   [Full Text] [Related]  

  • 7. Evaluation of cutoff levels for screening of gastric cancer using serum pepsinogens and distributions of levels of serum pepsinogen I, II and of PG I/PG II ratios in a gastric cancer case-control study.
    Aoki K; Misumi J; Kimura T; Zhao W; Xie T
    J Epidemiol; 1997 Sep; 7(3):143-51. PubMed ID: 9337512
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the validity of three biomarkers for gastric cancer screening: carcinoembryonic antigen, pepsinogens, and high sensitive C-reactive protein.
    Chung HW; Kim JW; Lee JH; Song SY; Chung JB; Kwon OH; Lim JB
    J Clin Gastroenterol; 2009 Jan; 43(1):19-26. PubMed ID: 18648315
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pepsinogen].
    Miki K
    Nihon Rinsho; 1995 May; 53(5):1198-202. PubMed ID: 7602778
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation of ratio of serum pepsinogen I and II with prevalence of gastric cancer and adenoma in Japanese subjects.
    Yoshihara M; Sumii K; Haruma K; Kiyohira K; Hattori N; Kitadai Y; Komoto K; Tanaka S; Kajiyama G
    Am J Gastroenterol; 1998 Jul; 93(7):1090-6. PubMed ID: 9672336
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Using serum pepsinogens wisely in a clinical practice.
    Miki K; Urita Y
    J Dig Dis; 2007 Feb; 8(1):8-14. PubMed ID: 17261129
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Distribution of serum pepsinogen I, II values and their ratios in residents of a rural area].
    Aoki K; Misumi J
    Nihon Koshu Eisei Zasshi; 1993 Apr; 40(4):313-22. PubMed ID: 8329751
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum levels of pepsinogen I and gastrin in gastric carcinoma: the influence of Helicobacter pylori infection and tumor characteristics.
    Lin JT; Wang JT; Wu MS; Huang SC; Wang TH
    Hepatogastroenterology; 1993 Dec; 40(6):600-3. PubMed ID: 8119648
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical significance of serum pepsinogen levels for prediction of recurrence in gastric carcinoma].
    Maeda K; Chung YS; Onoda N; Nishimura S; Nitta A; Arimoto Y; Kato Y; Sowa M
    Gan To Kagaku Ryoho; 1993 Oct; 20(13):2079-81. PubMed ID: 8215486
    [No Abstract]   [Full Text] [Related]  

  • 15. [Effectiveness and feasibility of a strategy for increasing participation in the Japanese Stomach Cancer Examination programs by incorporating serum pepsinogen tests].
    Kurosawa M; Kikuchi S; Arisue T; Fukao A
    Nihon Koshu Eisei Zasshi; 1998 Apr; 45(4):352-60. PubMed ID: 9691665
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term results of gastric cancer screening using the serum pepsinogen test method among an asymptomatic middle-aged Japanese population.
    Miki K; Fujishiro M; Kodashima S; Yahagi N
    Dig Endosc; 2009 Apr; 21(2):78-81. PubMed ID: 19691778
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Current issues and future prospects of gastric mass survey].
    Hisamichi S
    Gan No Rinsho; 1984 May; 30(6 Suppl):581-7. PubMed ID: 6748229
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The association of smoking and drinking habits with serum pepsinogens.
    Kikuchi S; Inaba Y; Wada O; Miki K; Tenjin H; Kaneko E; Mizukoshi H
    Int J Epidemiol; 1995 Apr; 24(2):346-53. PubMed ID: 7635595
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mass gastric examinations of prisoners at Miyagi Prison in Japan.
    Hisamichi S; Nozaki K; Shirane A; Sugawara N; Sato K
    Am J Gastroenterol; 1977 Jan; 67(1):34-9. PubMed ID: 851103
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Japanese guidelines for gastric cancer screening.
    Hamashima C; Shibuya D; Yamazaki H; Inoue K; Fukao A; Saito H; Sobue T
    Jpn J Clin Oncol; 2008 Apr; 38(4):259-67. PubMed ID: 18344316
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.